Kanellopoulos P

Evaluation of ABD-Linked RM26 Conjugates for GRPR-Targeted Drug Delivery.

Nagy Á, Abouzayed A, Kanellopoulos P, ..., Orlova A, Eriksson Karlström A

ACS Omega 9 (34) 36122-36133 [2024-08-27; online 2024-08-15]

Two Novel [68Ga]Ga-Labeled Radiotracers Based on Metabolically Stable [Sar11]RM26 Antagonistic Peptide for Diagnostic Positron Emission Tomography Imaging of GRPR-Positive Prostate Cancer.

Kanellopoulos P, Bezverkhniaia E, Abouzayed A, ..., Tolmachev V, Orlova A

ACS Omega 9 (16) 18608-18616 [2024-04-23; online 2024-04-10]

GRPR-Antagonists Carrying DOTAGA-Chelator via Positively Charged Linkers: Perspectives for Prostate Cancer Theranostics.

Obeid K, Kanellopoulos P, Abouzayed A, ..., Maina T, Orlova A

Pharmaceutics 16 (4) - [2024-04-08; online 2024-04-08]

Influence of Molecular Design on the Tumor Targeting and Biodistribution of PSMA-Binding Tracers Labeled with Technetium-99m.

Bezverkhniaia E, Kanellopoulos P, Rosenström U, Tolmachev V, Orlova A

Int J Mol Sci 25 (7) - [2024-03-23; online 2024-03-23]

Preclinical Evaluation of a Novel High-Affinity Radioligand [99mTc]Tc-BQ0413 Targeting Prostate-Specific Membrane Antigen (PSMA).

Bezverkhniaia E, Kanellopoulos P, Abouzayed A, ..., Tolmachev V, Orlova A

Int J Mol Sci 24 (24) - [2023-12-12; online 2023-12-12]